FDA: migraine drug ups risk for oral birth defects
WASHINGTON (Reuters) - An epilepsy drug also used to help prevent migraines can increase the risk for oral birth defects in babies born to women taking the medication, U.S. health officials said on Friday.
No comments:
Post a Comment